Discontinued — last reported Q4 '25
D&A
Elevance Health D&A decreased by 12.8% to $354.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 5.1%, from $373.00M to $354.00M. Over 4 years (FY 2021 to FY 2025), D&A shows an upward trend with a 4.4% CAGR.
Analysis
How to read this metric
Higher levels typically reflect significant historical capital expenditures or acquisitions that are now being expensed over time.
Detailed definition
This metric represents the non-cash accounting charges used to allocate the cost of tangible assets and intangible asset...
Peer comparison
Capital-intensive hardware manufacturers generally show higher D&A relative to revenue than pure-play software companies.
depreciation_and_amortization_cfHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $309.00M | $351.00M | $360.00M | $358.00M | $393.00M | $451.00M | $473.00M | $462.00M | $433.00M | $426.00M | $424.00M | $331.00M | $335.00M | $329.00M | $398.00M | $373.00M | $380.00M | $387.00M | $406.00M | $354.00M |
| QoQ Change | — | +13.6% | +2.6% | -0.6% | +9.8% | +14.8% | +4.9% | -2.3% | -6.3% | -1.6% | -0.5% | -21.9% | +1.2% | -1.8% | +21.0% | -6.3% | +1.9% | +1.8% | +4.9% | -12.8% |
| YoY Change | — | — | — | — | +27.2% | +28.5% | +31.4% | +29.1% | +10.2% | -5.5% | -10.4% | -28.4% | -22.6% | -22.8% | -6.1% | +12.7% | +13.4% | +17.6% | +2.0% | -5.1% |
Business Segments
| Segment | Q2 '23 | Q3 '23 | Q2 '24 | Q3 '24 |
|---|---|---|---|---|
| Corporate & Other | $221.00M | $220.00M | $234.00M | $231.00M |
| Carelon Services | $0.00 | $0.00 | $0.00 | $0.00 |
| CarelonRx | $0.00 | $0.00 | $0.00 | $0.00 |
| Health Benefits | $0.00 | $0.00 | $0.00 | $0.00 |
| Total | $433.00M | $426.00M | $335.00M | $329.00M |
Carelon Services, CarelonRx, Corporate & Other, Health Benefits were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
D&A at Other Companies
Frequently Asked Questions
- What is Elevance Health's d&a?
- Elevance Health (ELV) reported d&a of $354.00M in Q1 2026.
- How has Elevance Health's d&a changed year-over-year?
- Elevance Health's d&a decreased by 5.1% year-over-year, from $373.00M to $354.00M.
- What is the long-term trend for Elevance Health's d&a?
- Over 4 years (2021 to 2025), Elevance Health's d&a has grown at a 4.4% compound annual growth rate (CAGR), from $1.30B to $1.55B.
- What does d&a mean?
- The accounting process of spreading the cost of physical and intangible assets over time.